Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

The contribution of cell surface FcRn in monoclonal antibody serum uptake from the intestine in suckling rat pups.

Cooper PR, Kliwinski CM, Perkinson RA, Ragwan E, Mabus JR, Powers GD, Dorai H, Giles-Komar J, Hornby PJ.

Front Pharmacol. 2014 Oct 7;5:225. doi: 10.3389/fphar.2014.00225. eCollection 2014.

2.

Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity.

Anikeeva N, Steblyanko M, Fayngerts S, Kopylova N, Marshall DJ, Powers GD, Sato T, Campbell KS, Sykulev Y.

Eur J Immunol. 2014 Aug;44(8):2331-9. doi: 10.1002/eji.201344179. Epub 2014 Jun 5.

3.

Human and non-human primate intestinal FcRn expression and immunoglobulin G transcytosis.

Hornby PJ, Cooper PR, Kliwinski C, Ragwan E, Mabus JR, Harman B, Thompson S, Kauffman AL, Yan Z, Tam SH, Dorai H, Powers GD, Giles-Komar J.

Pharm Res. 2014 Apr;31(4):908-22. doi: 10.1007/s11095-013-1212-3. Epub 2013 Sep 26.

4.

Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice.

Kliwinski C, Cooper PR, Perkinson R, Mabus JR, Tam SH, Wilkinson TM, Giles-Komar J, Scallon B, Powers GD, Hornby PJ.

Am J Physiol Gastrointest Liver Physiol. 2013 Feb 1;304(3):G262-70. doi: 10.1152/ajpgi.00340.2012. Epub 2012 Dec 6.

5.

IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice.

Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt PH, Chen CH, Rosen CA, Stewart CL.

Mol Cell Biol. 1996 May;16(5):2341-9.

6.

Expression of soluble human interleukin-2 receptor alpha-chain in Escherichia coli.

Dracheva S, Palermo RE, Powers GD, Waugh DS.

Protein Expr Purif. 1995 Dec;6(6):737-47.

PMID:
8746625
7.

Monoclonal antibody 2D10 recognizes a novel T cell costimulatory molecule on activated murine B lymphocytes.

Chen C, Faherty DA, Gault A, Connaughton SE, Powers GD, Godfrey DI, Nabavi N.

J Immunol. 1994 Mar 1;152(5):2105-14.

PMID:
7510738
8.

Expression and functional analysis of murine B7 delineated by a novel monoclonal antibody.

Powers GD, Faherty DA, Connaughton SE, Biondi DA, Godfrey DI, Gault A, Chen CY, Nabavi N.

Cell Immunol. 1994 Feb;153(2):298-311.

PMID:
7509723
9.

Comparative toxicity and pathology associated with administration of recombinant IL-2 to animals.

Anderson TD, Hayes TJ, Powers GD, Gately MK, Tudor R, Rushton A.

Int Rev Exp Pathol. 1993;34 Pt A:57-77. Review. No abstract available.

PMID:
8454417
10.
11.

Frequencies of IL-2- and IL-4-secreting T cells in naive and antigen-stimulated lymphocyte populations.

Powers GD, Abbas AK, Miller RA.

J Immunol. 1988 May 15;140(10):3352-7.

PMID:
3258881
12.
13.

Regs muddy re-funding analysis.

Powers GD, Elrod JL Jr.

Mod Healthc. 1983 Jun;13(6):118, 121-2. No abstract available.

PMID:
10260328
14.

Religion and hospital finance: a look at zero coupon bond idea.

Powers GD.

Rev Fed Am Hosp. 1983 Jan-Feb;16(1):48-50. No abstract available.

PMID:
10298757

Supplemental Content

Loading ...
Support Center